A groundbreaking study published in PLOS One reveals that medicinal cannabis significantly improves health-related quality of life (HRQL) for patients with chronic conditions over a 12-month period. Conducted by researchers from The University of Sydney, the QUEST initiative tracked 2,353 participants prescribed medicinal cannabis for conditions such as anxiety, depression, chronic pain, and insomnia. Improvements in fatigue, pain, and sleep were sustained long-term, with notable gains in HRQL across physical, emotional, and social domains.

While the study lacked a control group to definitively attribute these benefits to medicinal cannabis, the findings highlight its potential as a therapeutic option for patients unresponsive to conventional treatments. The authors emphasize that this data contributes to informed decision-making in clinical practice and policy development.

For more details, read the full study on PLOS One: https://plos.io/4bIvkNp.